Statin Needs to be Continued During Paxlovid Therapy in COVID-19.
作者信息
Vuorio Alpo, Kovanen Petri T, Raal Frederick
机构信息
Mehiläinen Airport Health Centre, Vantaa, Finland.
Department of Forensic Medicine, University of Helsinki, Helsinki, Finland.
出版信息
Clin Infect Dis. 2022 Dec 19;75(12):2281-2282. doi: 10.1093/cid/ciac667.
Abstract
摘要
相似文献
1
Statin Needs to be Continued During Paxlovid Therapy in COVID-19.新冠病毒感染接受帕罗韦德治疗期间他汀类药物需持续使用。
Clin Infect Dis. 2022 Dec 19;75(12):2281-2282. doi: 10.1093/cid/ciac667.
2
Reassessing withholding of statins during Paxlovid therapy: Is it worth risking loss of the pleiotropic effects of statins and cardiovascular protection?重新评估帕罗韦德治疗期间停用他汀类药物的做法：冒着失去他汀类药物多效性作用和心血管保护作用的风险是否值得？
Am J Health Syst Pharm. 2023 Sep 7;80(18):1204-1205. doi: 10.1093/ajhp/zxad135.
3
HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.羟甲基戊二酰辅酶 A 还原酶抑制剂与瑞典斯德哥尔摩地区 COVID-19 死亡率：一项基于登记的队列研究。
PLoS Med. 2021 Oct 14;18(10):e1003820. doi: 10.1371/journal.pmed.1003820. eCollection 2021 Oct.
4
The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.HMG-CoA还原酶抑制剂的使用对COVID-19危重症患者临床结局的影响：一项多中心队列研究。
Front Public Health. 2022 Aug 11;10:877944. doi: 10.3389/fpubh.2022.877944. eCollection 2022.
5
Statin Therapy in COVID-19: Inhibition of NETosis.新冠病毒肺炎中的他汀类药物治疗：对中性粒细胞胞外诱捕网形成的抑制作用
J Gen Intern Med. 2023 Mar;38(4):1077. doi: 10.1007/s11606-022-07964-w. Epub 2022 Nov 22.
6
Statin and cancer risks: from tasseomancy of epidemiologic studies to meta-analyses.他汀类药物与癌症风险：从流行病学研究的占卜到荟萃分析
J Clin Oncol. 2006 Oct 20;24(30):4796-7. doi: 10.1200/JCO.2006.07.9673. Epub 2006 Sep 25.
7
Considerations for Statin Therapy in Patients with COVID-19.新型冠状病毒肺炎患者他汀类药物治疗的考量因素
Pharmacotherapy. 2020 May;40(5):484-486. doi: 10.1002/phar.2397. Epub 2020 May 4.
8
In-Hospital Statin Treatment of COVID-19.新冠病毒病的院内他汀类药物治疗
J Infect Dis. 2023 Mar 1;227(5):731-732. doi: 10.1093/infdis/jiab601.
9
Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19): Reconsideration is needed.他汀类药物与2019冠状病毒病（COVID-19）结局的荟萃分析：需要重新考虑。
Nutr Metab Cardiovasc Dis. 2021 Aug 26;31(9):2737-2739. doi: 10.1016/j.numecd.2021.06.009. Epub 2021 Jul 5.
10
Statin therapy is associated with less ICU admissions in COVID-19 patients.他汀类药物治疗与新冠病毒感染患者入住重症监护病房的人数减少有关。
Minerva Anestesiol. 2021 Aug;87(8):951-952. doi: 10.23736/S0375-9393.21.15600-7. Epub 2021 Mar 10.
引用本文的文献
1
Familial Hypercholesterolemia Patients with COVID-19-Effective Cholesterol-Lowering Therapy is Urgent both during and after Infection.家族性高胆固醇血症合并新型冠状病毒肺炎患者——感染期间及感染后均急需有效的降胆固醇治疗
Rev Cardiovasc Med. 2022 Dec 19;23(12):410. doi: 10.31083/j.rcm2312410. eCollection 2022 Dec.
2
Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries.沙坦类药物中的量子药理学存在：在离体兔髂动脉中的证据。
Int J Mol Sci. 2023 Dec 16;24(24):17559. doi: 10.3390/ijms242417559.
3
Angiotensin II constricts mouse iliac arteries: possible mechanism for aortic aneurysms.血管紧张素 II 收缩小鼠髂动脉：主动脉瘤的可能机制。
Mol Cell Biochem. 2024 Feb;479(2):233-242. doi: 10.1007/s11010-023-04724-0. Epub 2023 Apr 7.
Zotero 插件